Teasel Root

Dipsacus asper (Teasel Root) contains iridoid saponins and phenolic compounds that may have anticoagulant or antiplatelet properties at pharmacological doses. Preclinical evidence suggests possible pro-coagulant effects at higher concentrations (developmental toxicity and coagulation studies), creating an unpredictable interaction. Clinical case reports of perioperative bleeding risk with related Dipsacus species extracts have been noted.

Exercise caution when Teasel Root is used with anticoagulants or antiplatelet medications. Monitor for signs of abnormal bleeding. Discontinue Teasel Root at least 2 weeks before elective surgery or invasive procedures. Inform healthcare providers of Teasel Root use.

Dipsacus asper extracts contain iridoid glycosides (asperosaponin VI) and phenolic compounds that demonstrate immunomodulatory effects in preclinical models, including macrophage activation and cytokine production modulation. These immunostimulatory properties may potentially reduce the effectiveness of immunosuppressive therapy in transplant recipients or patients with autoimmune conditions.

Organ transplant recipients and patients on immunosuppressive therapy should avoid Teasel Root supplementation or consult their specialist team before use. The risk is theoretical based on pharmacological properties; clinical case reports of direct immunosuppressant antagonism are not yet available.

Some sources report potential estrogenic activity of Teasel root constituents based on structural similarities of iridoid glycosides to phytoestrogens. If confirmed, these weak estrogenic effects could theoretically interfere with hormonal balance in women using hormonal contraceptives or HRT by competing at estrogen receptors or altering estrogen metabolism.

Women using hormonal contraceptives or HRT who are considering Teasel Root supplementation should consult their healthcare provider. The estrogenic activity evidence is primarily theoretical. Monitor for changes in menstrual cycle regularity or breakthrough bleeding.

Dipsacus asper root extracts have demonstrated significant anti-inflammatory activity in preclinical models, including anti-rheumatoid effects comparable to indomethacin (1 mg/kg) through suppression of TNF-α, IL-1β, and IL-6 in collagen-induced arthritis models. Combined anti-inflammatory action with NSAIDs or corticosteroids may produce additive therapeutic benefit but also increased risk of GI adverse effects.

When Teasel Root is used alongside NSAIDs for musculoskeletal conditions (its primary traditional indication), monitor for GI adverse effects (nausea, GI bleeding). The combination may allow reduced NSAID dosing in some patients, which could be clinically beneficial.

Dipsacus asper iridoid glycosides including loganin and sweroside have hepatoprotective properties that may modulate CYP enzyme activity and alter hepatic glucose metabolism. Preclinical data suggest mild hypoglycemic properties. Additive blood glucose lowering with antidiabetic medications is theoretically possible.

Monitor blood glucose if Teasel Root is used alongside antidiabetic medications. The interaction evidence is primarily theoretical and preclinical. Educate patients on hypoglycemia recognition. Inform prescribers of Teasel Root use.